Platelet fluctuations during thrombopoietin-receptor agonist treatment: correlation with platelet apoptosis

Ann Hematol. 2015 Feb;94(2):339-41. doi: 10.1007/s00277-014-2156-3. Epub 2014 Jul 4.

Authors

Nicola Polverelli¹, Lucia Catani, Daria Sollazzo, Nicola Vianelli, Francesca Palandri

Affiliation

¹ Institute of Hematology "L. and A. Seràgnoli", St Orsola-Malpighi Hospital, Department of Specialistic, Diagnostic and Experimental Medicine, University of Bologna, Via Massarenti 9, 40138, Bologna, Italy.

PMID: 24994539
DOI: 10.1007/s00277-014-2156-3

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Apoptosis / drug effects*
Benzoates / adverse effects
Blood Platelets / drug effects*
Female
Humans
Hydrazines / adverse effects
Platelet Count
Purpura, Thrombocytopenic, Idiopathic / blood*
Purpura, Thrombocytopenic, Idiopathic / drug therapy
Pyrazoles / adverse effects
Receptors, Fc
Receptors, Thrombopoietin / agonists*
Recombinant Fusion Proteins / adverse effects
Thrombopoietin / adverse effects
Time Factors

Substances

Benzoates
Hydrazines
Pyrazoles
Receptors, Fc
Receptors, Thrombopoietin
Recombinant Fusion Proteins
Thrombopoietin
romiplostim
eltrombopag